Laporan Laba Rugi 2348 - TTM - Dawnrays Pharmaceutical (Holdings) Limited

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Dawnrays Pharmaceutical (Holdings) Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	986	1,024	1,084	1,144	1,155	1,165	1,173	1,180	1,229	1,278	1,291	1,304	1,228	1,151	1,115	1,079	1,069	1,060	1,087	1,113
Change (%)		3.85	5.84	5.52	0.93	0.92	0.64	0.63	4.14	3.97	1.03	1.02	-5.87	-6.23	-3.15	-3.25	-0.85	-0.86	2.50	2.44
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	464	479	492	505	497	490	485	480	496	511	540	570	546	523	508	494	511	528	566	604
Change (%)		3.09	2.72	2.65	-1.48	-1.51	-0.96	-0.97	3.18	3.09	5.75	5.44	-4.13	-4.31	-2.75	-2.83	3.48	3.36	7.15	6.68
% of Revenue	47.08	46.74	45.36	44.13	43.07	42.04	41.37	40.71	40.34	39.99	41.86	43.69	44.49	45.40	45.59	45.79	47.79	49.82	52.08	54.24

Gross Operating Profit	522	546	592	639	657	675	688	700	733	767	751	734	681	628	607	585	558	532	521	509
Change (%)		4.54	8.57	7.90	2.84	2.76	1.80	1.77	4.79	4.57	-2.11	-2.15	-7.21	-7.77	-3.48	-3.60	-4.51	-4.72	-2.12	-2.17
% of Revenue	52.92	53.26	54.64	55.87	56.93	57.96	58.63	59.29	59.66	60.01	58.14	56.31	55.51	54.60	54.41	54.21	52.21	50.18	47.92	45.76

SG&A	169	164	182	200	213	226	230	234	249	265	262	260	260	260	258	255	257	258	259	259
Change (%)		-3.27	11.06	9.96	6.60	6.19	1.57	1.55	6.68	6.27	-0.93	-0.94	0.08	0.08	-0.98	-0.99	0.60	0.60	0.24	0.24
% of Revenue	17.17	15.99	16.78	17.49	18.47	19.43	19.61	19.79	20.28	20.72	20.32	19.92	21.18	22.61	23.11	23.65	24.00	24.35	23.82	23.31

R&D	40	58	61	63	65	67	68	69	74	79	80	80	86	91	97	104	87	71	77	84
Change (%)		43.22	4.46	4.27	3.10	3.00	1.35	1.34	7.72	7.17	0.50	0.50	6.56	6.15	7.23	6.74	-15.92	-18.94	9.13	8.37
% of Revenue	4.10	5.66	5.58	5.52	5.64	5.75	5.79	5.83	6.03	6.22	6.19	6.16	6.97	7.89	8.73	9.63	8.17	6.68	7.11	7.52

OpEx	694	704	732	761	773	784	784	785	822	859	888	918	897	875	862	850	854	858	907	956
Change (%)		1.46	4.07	3.91	1.53	1.51	0.01	0.01	4.71	4.50	3.47	3.35	-2.34	-2.39	-1.46	-1.48	0.51	0.50	5.67	5.37
% of Revenue	70.33	68.71	67.56	66.54	66.93	67.32	66.90	66.49	66.86	67.20	68.81	70.40	73.04	76.02	77.35	78.77	79.85	80.94	83.45	85.84

Operating Income	293	320	352	383	382	381	388	395	407	419	403	386	331	276	253	229	216	202	180	158
Change (%)		9.54	9.71	8.85	-0.26	-0.26	1.93	1.89	2.99	2.91	-3.95	-4.11	-14.25	-16.62	-8.51	-9.30	-5.89	-6.26	-10.99	-12.34
% of Revenue	29.67	31.29	32.44	33.46	33.07	32.68	33.10	33.51	33.14	32.80	31.19	29.60	26.96	23.98	22.65	21.23	20.15	19.06	16.55	14.16

Interest Expense	-6	-5	-3	-1	-1	-1	-1	-1	-1	-0	-0	-0	-1	-1	-2	-3	-3	-4	-2	-1
Change (%)		-23.91	-35.28	-54.52	-27.45	-37.83	5.54	5.25	-23.95	-31.49	14.56	12.71	53.24	34.74	117.64	54.05	4.40	4.22	-32.51	-48.17
% of Revenue	-0.64	-0.47	-0.29	-0.12	-0.09	-0.06	-0.06	-0.06	-0.04	-0.03	-0.03	-0.04	-0.06	-0.09	-0.19	-0.31	-0.32	-0.34	-0.22	-0.11

Net Income	251	268	287	305	332	358	361	363	361	358	400	442	384	326	445	563	564	565	371	176
Change (%)		6.65	6.89	6.45	8.70	8.00	0.70	0.70	-0.71	-0.71	11.77	10.53	-13.15	-15.14	36.37	26.67	0.16	0.16	-34.38	-52.40
% of Revenue	25.49	26.18	26.44	26.67	28.72	30.74	30.76	30.78	29.35	28.02	31.00	33.92	31.29	28.32	39.87	52.20	52.74	53.28	34.11	15.85

Source: Capital IQ

Dawnrays Pharmaceutical (Holdings) Limited - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)